Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KNSA - Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A


IEX Last Trade
26.75
-0.010   -0.037%

Share volume: 227,263
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$26.76
-0.01
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-04 2022-11-03 2023-03-02 2023-05-04 2023-08-01 2023-11-02 2024-02-28 2024-04-25
Total revenue 26.972 M 99.135 M 61.884 M 48.345 M 71.473 M 67.046 M 83.395 M 79.858 M
Cost of revenue 5.029 M 6.937 M 6.710 M 7.036 M 7.699 M 9.088 M 9.584 M 10.583 M
Gross profit 21.943 M 92.198 M 55.174 M 41.309 M 63.774 M 57.958 M 73.811 M 69.275 M
    320.17% -40.16% -25.13% 54.38% -9.12% 27.35% -6.15%  
Operating expenses 37.639 M 41.162 M 41.605 M 44.217 M 52.942 M 51.574 M 56.791 M 65.016 M
Selling general and admin 23.841 M 24.677 M 27.215 M 29.045 M 29.175 M 34.468 M 36.739 M 38.682 M
Research and development 13.798 M 16.485 M 14.390 M 15.172 M 23.767 M 17.106 M 20.052 M 26.334 M
Total expenses 46.340 M 52.722 M 55.837 M 59.541 M 74.627 M 77.973 M 83.314 M 96.400 M
    13.77% 5.91% 6.63% 25.34% 4.48% 6.85% 15.71%  
Operating income -19.368 M 46.413 M 6.047 M -11.196 M -3.154 M -10.927 M 81.000 K -16.542 M
Ebit -19.368 M 46.413 M 6.047 M -11.196 M -3.154 M -10.927 M 81.000 K -16.542 M
Pretax income -19.265 M 46.735 M 6.841 M -9.364 M -1.239 M -8.499 M 2.450 M -14.276 M
    -342.59% -85.36% -236.88% -86.77% 585.96% -128.83% -682.69%  
Income tax 716.000 K -177.358 M 2.380 M 2.906 M -16.211 M 5.356 M -22.787 M 3.428 M
Net income basic -19.981 M 224.093 M 4.461 M -12.270 M 14.972 M -13.855 M 25.237 M -17.704 M
    1,221.53% -98.01% -375.05% 222.02% -192.54% 282.15% -170.15%  
Net income -19.981 M 224.093 M 4.461 M -12.270 M 14.972 M -13.855 M 25.237 M -17.704 M
    1,221.53% -98.01% -375.05% 222.02% -192.54% 282.15% -170.15%